Chrousos Phaedra

Chrousos Phaedra is listed in filings as Director at Vanda Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Jun 8, 2026, including 2 public disclosures. Recent filings connect the profile to Vanda Pharmaceuticals Inc. (VNDA). The current snapshot covers public activity from Jun 9, 2025 to Jun 8, 2026. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.